Royalty Pharma Raises 2026 Receipts Outlook After 9% Q3 Growth

Royalty Receipts rose to $883 million, while net income attributable to the company fell to $144.7 million.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.